Acrobat Genomics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 10

Acrobat Genomics General Information

Description

Developer of a protein engineering platform designed to improve the development of therapeutic and biological proteins. The company's platform offers high-throughput functional screening in human cells and generative machine learning models, enabling biotechnology and pharmaceutical organizations to develop protein candidates with improved precision and research efficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States
+1 (415)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States
+1 (415)

Acrobat Genomics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acrobat Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 08-Jul-2025 Completed Generating Revenue
6. Early Stage VC 31-Dec-2024 Completed Generating Revenue
5. Early Stage VC 01-Apr-2024 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
3. Grant 01-Jan-2024 Completed Generating Revenue
2. Early Stage VC 12-Dec-2022 Completed Generating Revenue
1. Accelerator/Incubator 14-Sep-2022 Completed Generating Revenue
To view Acrobat Genomics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Acrobat Genomics Patents

Acrobat Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025006495-A1 Tnpb-related endonucleases Inactive 26-Jun-2023

Acrobat Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acrobat Genomics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Plug and Play Accelerator/Incubator Minority
Reinforced Ventures Venture Capital Minority
California Life Sciences Accelerator/Incubator
U.S. Department of Health and Human Services Government
First In Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Acrobat Genomics FAQs

  • When was Acrobat Genomics founded?

    Acrobat Genomics was founded in 2022.

  • Where is Acrobat Genomics headquartered?

    Acrobat Genomics is headquartered in San Carlos, CA.

  • What is the size of Acrobat Genomics?

    Acrobat Genomics has 4 total employees.

  • What industry is Acrobat Genomics in?

    Acrobat Genomics’s primary industry is Biotechnology.

  • Is Acrobat Genomics a private or public company?

    Acrobat Genomics is a Private company.

  • What is Acrobat Genomics’s current revenue?

    The current revenue for Acrobat Genomics is .

  • How much funding has Acrobat Genomics raised over time?

    Acrobat Genomics has raised $1M.

  • Who are Acrobat Genomics’s investors?

    Plug and Play, Reinforced Ventures, California Life Sciences, U.S. Department of Health and Human Services, and First In Ventures are 5 of 10 investors who have invested in Acrobat Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process